Print Page     Close Window     

SEC Filings

SERES THERAPEUTICS, INC. filed this Form 10-Q on 11/08/2018
Entire Document

Exhibit 10.1


This Employment Agreement (this “Agreement”), dated as of October 5, 2018, is made by and between Seres Therapeutics, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Kevin Horgan, M.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).



It is the desire of the Company to assure itself of the services of Executive by entering into this Agreement.


Executive and the Company mutually desire that Executive be employed by the Company on the terms herein provided, commencing on October 22, 2018 or another date mutually agreed by the Parties (the date Executive actually commences such employment, the “Effective Date”).


This Agreement will become effective upon the Effective Date.


NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the Parties hereto agree as follows:


(a)General.  Effective on the Effective Date, the Company shall employ Executive and Executive shall remain in the employ of the Company, for the period and in the positions set forth in this Section 1, and subject to the other terms and conditions herein provided.

(b)At-Will Employment.  The Company and Executive acknowledge that Executive’s employment is and shall continue to be at-will, as defined under applicable law, and that Executive’s employment with the Company may be terminated by either Party at any time for any or no reason (subject to the notice requirements of Section 3(b)).  This “at-will” nature of Executive’s employment shall remain unchanged during Executive’s tenure as an employee and may not be changed, except in an express writing signed by Executive and a duly authorized officer of the Company.  If Executive’s employment terminates for any reason, Executive shall not be entitled to any payments, benefits, damages, award or compensation other than as provided in this Agreement or otherwise agreed to in writing by the Company or as provided by applicable law.  The term of this Agreement (the “Term”) shall commence on the Effective Date and end on the date this Agreement is terminated under Section 3.

(c)Positions and Duties.  Executive shall serve as Executive Vice President and Chief Medical Officer of the Company, reporting directly to the Chief Executive Officer (“CEO”) of the Company, with such responsibilities, duties and authority normally associated with such positions and as may from time to time be assigned to Executive by the CEO of the Company.  Executive shall devote substantially all of Executive’s working time and efforts to the



© Seres Therapeutics. All Rights Reserved.